“✒베스트토토안전【평생베스트.com】베스트먹튀✒”的搜索结果，显示 81-90 项，共有 3017 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

2. 脊柱保健- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and effectiveness of Adherus Dural Sealant when used in conjunction with standard methods of dural ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

5. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop and maintain a registry of clinical data and biological specimens from patients with immune system related blood ...

6. 眼科 - 临床试验- 妙佑医疗国际

   The objectives of this study are: To evaluate patient-reported quality of life and functional vision across the spectrum of pediatric eye conditions; ...

7. 泌尿科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes. A Study to Develop ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

10. 泌尿科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...